IgA nephropathy (NORD)
00:00 / 00:00
Videos
Notes
IgA nephropathy (NORD)
Information for patients and families
Glut1 Deficiency Foundation
Glut1 deficiency syndrome (Glut1 Deficiency Foundation)
Gorlin Syndrome Alliance
Gorlin syndrome (Gorlin Syndrome Alliance)
The National Organization for Rare Disorders (NORD)
Recurrent pericarditis (NORD)
Autoimmune polyglandular syndrome type 1 (NORD)
Opsoclonus myoclonus syndrome (NORD)
Thyroid eye disease (NORD)
Bile synthesis disorders (NORD)
Cyclic vomiting syndrome (NORD)
Eosinophilic esophagitis (NORD)
Short bowel syndrome (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Sickle cell disease (NORD)
Waldenstrom macroglobulinemia (NORD)
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Congenital athymia (NORD)
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Severe chronic neutropenia (NORD)
Adrenoleukodystrophy (NORD)
Alagille syndrome (NORD)
Aromatic L-amino acid decarboxylase deficiency (NORD)
Cerebrotendinous xanthomatosis (NORD)
Classical homocystinuria (NORD)
Congenital cytomegalovirus (NORD)
Cystinuria (NORD)
Fabry disease (NORD)
Gaucher disease (NORD)
Glycogen storage disease type II (NORD)
Metachromatic leukodystrophy (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Mycobacterium avium complex (NORD)
NGLY1 deficiency (NORD)
Niemann-Pick disease types A and B (NORD)
Phenylketonuria (NORD)
PIK3CA-related overgrowth spectrum (NORD)
Tay-Sachs disease (NORD)
Zellweger spectrum disorders (NORD)
Early infantile epileptic encephalopathy (NORD)
Opsoclonus myoclonus syndrome (NORD)
Spinocerebellar ataxia (NORD)
Narcolepsy (NORD)
Focal segmental glomerulosclerosis (NORD)
IgA nephropathy (NORD)
Pulmonary arterial hypertension (NORD)
The Primary School
ADHD: Information for patients and families (The Primary School)
Asthma: Information for patients and families (The Primary School)
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Childhood oral health: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Toxic stress: Information for patients and families (The Primary School)
Assessments
IgA nephropathy (NORD)
Flashcards
0 / 9 complete
USMLE® Step 1 questions
0 / 2 complete
High Yield Notes
10 pages
Flashcards
IgA nephropathy (NORD)
of complete
Questions
USMLE® Step 1 style questions USMLE
of complete
Which of the following changes would most likely be present on this patient’s renal biopsy?
External References
First Aid
2022
2021
2020
2019
2018
2017
2016
Hematuria p. 620
IgA nephropathy p. 620
IgA nephropathy p. 620
Henoch-Schönlein purpura and p. 322
Transcript
Content Reviewers
Contributors
IgA is a class of immunoglobulin, or antibody, and nephropathy means kidney disease.
IgA nephropathy, sometimes known as Berger disease, is the most common form of nephropathy worldwide, and it happens when an abnormal IgA forms and deposits in the kidneys, causing kidney damage.
IgA is the main antibody found in breast milk, tears, saliva, and the mucosal secretions of respiratory tract, gastrointestinal tract, and the genitourinary tract.
Unlike other antibodies, IgA can be secreted out in pairs or a dimeric form called secretory IgA, which is literally two IgA antibodies attached together.
By being bound together, it helps both antibodies avoid degradation by proteolytic enzymes in harsh environments like the gut.
Now, IgA comes in subclasses—IgA1 and IgA2, IgA1 is found mainly in the serum while IgA2 is more often found in the mucus secretions, typically in its dimeric form.
Now, the hinge region of the IgA1 heavy chain—the part that gives the antibody a bit of flexibility to bind multiple antigens without being torn apart—is made up of a string of amino acids.
Among these are serine and threonine residues which are O-linked glycosylated, meaning they have a sugar molecule, specifically galactose, attached to their oxygen.
Now these glycosylated IgA1 antibodies are identified by the body and degraded when too much of it accumulates.
In IgA nephropathy, though, there is abnormal glycosylation of these serine and threonine residues, causing them to be galactose-deficient.
These galactose-deficient IgA1s are not identified by the body, and therefore not degraded, allowing them to simply accumulate in the body.
In addition, it’s thought that these galactose-deficient IgA1 antibodies are different enough from normal IgA1 antibodies that the body no longer recognizes them as self.
In response, the body generates IgG antibodies that target the abnormally glycosylated residues. And these are known as anti-glycan IgG antibodies.
When these anti-glycan IgG antibodies bind to abnormal IgA1, immune complexes are formed.
These immune complexes can travel through the bloodstream where they get trapped at sites of filtration, like the kidney.
For Institutions
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
